Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
iGATE analysis improves the interpretability of single-cell immune landscape of influenza infection
Brett D. Hill, … , Daniel R. Goldstein, Fei Wen
Brett D. Hill, … , Daniel R. Goldstein, Fei Wen
Published May 30, 2024
Citation Information: JCI Insight. 2024;9(12):e172140. https://doi.org/10.1172/jci.insight.172140.
View: Text | PDF
Research Article Immunology Virology

iGATE analysis improves the interpretability of single-cell immune landscape of influenza infection

  • Text
  • PDF
Abstract

Influenza poses a persistent health burden worldwide. To design equitable vaccines effective across all demographics, it is essential to better understand how host factors such as genetic background and aging affect the single-cell immune landscape of influenza infection. Cytometry by time-of-flight (CyTOF) represents a promising technique in this pursuit, but interpreting its large, high-dimensional data remains difficult. We have developed a new analytical approach, in silico gating annotating training elucidating (iGATE), based on probabilistic support vector machine classification. By rapidly and accurately “gating” tens of millions of cells in silico into user-defined types, iGATE enabled us to track 25 canonical immune cell types in mouse lung over the course of influenza infection. Applying iGATE to study effects of host genetic background, we show that the lower survival of C57BL/6 mice compared with BALB/c was associated with a more rapid accumulation of inflammatory cell types and decreased IL-10 expression. Furthermore, we demonstrate that the most prominent effect of aging is a defective T cell response, reducing survival of aged mice. Finally, iGATE reveals that the 25 canonical immune cell types exhibited differential influenza infection susceptibility and replication permissiveness in vivo, but neither property varied with host genotype or aging. The software is available at https://github.com/UmichWenLab/iGATE.

Authors

Brett D. Hill, Andrew J. Zak, Sanjeev Raja, Luke F. Bugada, Syed M. Rizvi, Saiful B. Roslan, Hong Nhi Nguyen, Judy Chen, Hui Jiang, Akira Ono, Daniel R. Goldstein, Fei Wen

×

Figure 5

Expression profiling of iHA and sHA in 25 canonical immune cell types.

Options: View larger image (or click on image) Download as PowerPoint
Expression profiling of iHA and sHA in 25 canonical immune cell types.
F...
Fraction of intracellular HA–positive (%iHA+) cells by cell type for C57Y (A) phagocytes and (B) nonphagocytes at 3DPI. (C) %iHA+sHA+ by cell type for phagocytes (purple) and nonphagocytes (orange) at 3DPI. (D) Mean percentage of cell subsets expressing functional marker for iHA+sHA+ cells, iHA+sHA– cells, and iHA–sHA– cells at 3DPI. Each dot represents data for 1 cell type, and lines connect dots of the same cell type. Data represent mean ±SEM, n = 10. Statistical comparisons were computed by paired 1-way ANOVA with post hoc Tukey’s pairwise comparisons. *q < 0.10; **q < 0.01; ***q < 0.001; ****q < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts